BR112012020965A2 - tratamento de condições alérgicas dermatológicas - Google Patents

tratamento de condições alérgicas dermatológicas

Info

Publication number
BR112012020965A2
BR112012020965A2 BR112012020965A BR112012020965A BR112012020965A2 BR 112012020965 A2 BR112012020965 A2 BR 112012020965A2 BR 112012020965 A BR112012020965 A BR 112012020965A BR 112012020965 A BR112012020965 A BR 112012020965A BR 112012020965 A2 BR112012020965 A2 BR 112012020965A2
Authority
BR
Brazil
Prior art keywords
treatment
allergic conditions
dermatological allergic
dermatological
conditions
Prior art date
Application number
BR112012020965A
Other languages
English (en)
Inventor
Anne Minnich
Niel Fitch
Yong Mi Choi-Sledeski
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BR112012020965A2 publication Critical patent/BR112012020965A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

tratamento de condições alérgicas dermatológicas. a presente invenção refere-se a um tratamento para uma doença alérgica dermatológica, usando um composto: como [4-(5-aminometil-2-fluorfenil)piperidina-1-il] [7-flúor--(2-metoxietil)-4-trifluormetóxi 1h-indol-3-il]metanona.
BR112012020965A 2010-02-24 2011-02-23 tratamento de condições alérgicas dermatológicas BR112012020965A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30765010P 2010-02-24 2010-02-24
FR1060021 2010-12-02
PCT/US2011/025785 WO2011106334A1 (en) 2010-02-24 2011-02-23 Treatment of dermatological allergic conditions

Publications (1)

Publication Number Publication Date
BR112012020965A2 true BR112012020965A2 (pt) 2016-05-03

Family

ID=43901272

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012020965A BR112012020965A2 (pt) 2010-02-24 2011-02-23 tratamento de condições alérgicas dermatológicas

Country Status (15)

Country Link
US (1) US20120309790A1 (pt)
EP (1) EP2538942A1 (pt)
JP (1) JP2013520506A (pt)
KR (1) KR20130009769A (pt)
CN (1) CN102858336A (pt)
AR (1) AR080255A1 (pt)
AU (1) AU2011220909A1 (pt)
BR (1) BR112012020965A2 (pt)
CA (1) CA2790946A1 (pt)
MX (1) MX2012009523A (pt)
RU (1) RU2521357C2 (pt)
SG (1) SG183342A1 (pt)
TW (1) TW201141478A (pt)
UY (1) UY33242A (pt)
WO (1) WO2011106334A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
DOP2005000039A (es) * 2004-03-26 2005-10-31 Aventis Pharma Inc Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
JP5656834B2 (ja) * 2008-08-22 2015-01-21 サノフイ 肥満細胞トリプターゼインヒビターとしての［４−（５−アミノメチル−２−フルオロ−フェニル）−ピペリジン−１−イル］−［７−フルオロ−１−（２−メトキシ−エチル）−４−トリフルオロメトキシ−１ｈ−インドール−３−イル］−メタノン

Also Published As

Publication number Publication date
AR080255A1 (es) 2012-03-21
UY33242A (es) 2011-09-30
RU2012140438A (ru) 2014-03-27
US20120309790A1 (en) 2012-12-06
MX2012009523A (es) 2012-08-31
JP2013520506A (ja) 2013-06-06
CN102858336A (zh) 2013-01-02
TW201141478A (en) 2011-12-01
RU2521357C2 (ru) 2014-06-27
CA2790946A1 (en) 2011-09-01
AU2011220909A1 (en) 2012-09-13
SG183342A1 (en) 2012-09-27
WO2011106334A1 (en) 2011-09-01
EP2538942A1 (en) 2013-01-02
KR20130009769A (ko) 2013-01-23

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
CL2016001733A1 (es) Compuestos intermediarios para la preparación de compuestos derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer div. sol. 3415-12.
GEP20166438B (en) Imidazopyrrolidinone compounds
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CR20130045A (es) Compuestos terapéuticos
MX348451B (es) Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparación y su uso como antagonistas p2y12.
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
CO6480975A2 (es) Mimetico de smac
UY33735A (es) Compuestos antivirales
GEP20135933B (en) Compounds as bradykinin b1 antagonists
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
EA201100299A1 (ru) Органические соединения
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
EA201170832A1 (ru) Пуриновые соединения
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EA201490423A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА
EA201490152A1 (ru) Антагонисты trpm8 и их применение при лечении
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201201296A1 (ru) Способы лечения диабетических язв стопы
EA201270728A1 (ru) Пуриновые соединения

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]